|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 58.30 TWD | -6.27% |
|
+2.28% | -2.02% |
Company Valuation: Bionime Corporation
Data adjusted to current consolidation scope
| Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| Market Cap 1 | 4,057 | 4,566 | 4,685 | 4,549 | 3,949 | 4,003 |
| Change | - | 12.53% | 2.61% | -2.9% | -13.19% | 1.37% |
| Enterprise Value (EV) 1 | 5,664 | 6,284 | 6,677 | 6,917 | 6,733 | 6,577 |
| Change | - | 10.94% | 6.25% | 3.59% | -2.65% | -2.32% |
| P/E | 65.9x | 52.6x | 52.2x | 748x | -31x | -22.2x |
| PBR | 1.96x | 2.21x | 2.26x | 2.29x | 2.1x | 2.29x |
| PEG | - | 1.3x | 18.78x | -8x | 0x | -0.5x |
| Capitalization / Revenue | 2.43x | 2.47x | 2.12x | 2.59x | 2.04x | 2.18x |
| EV / Revenue | 3.39x | 3.4x | 3.02x | 3.94x | 3.48x | 3.58x |
| EV / EBITDA | 33.6x | 29.4x | 25x | 54x | 10,327x | -157x |
| EV / EBIT | 268x | 83.5x | 50.8x | -519x | -43.4x | -33.3x |
| EV / FCF | -84.5x | -119x | -34.4x | -26.3x | -25.7x | 28.9x |
| FCF Yield | -1.18% | -0.84% | -2.91% | -3.81% | -3.9% | 3.46% |
| Dividend per Share 2 | 1.875 | 1.818 | 1.909 | 1.818 | - | - |
| Rate of return | 3.04% | 2.64% | 2.72% | 2.67% | - | - |
| EPS 2 | 0.9365 | 1.309 | 1.346 | 0.0909 | -1.9 | -2.683 |
| Distribution rate | 200% | 139% | 142% | 2,000% | - | - |
| Net sales 1 | 1,669 | 1,850 | 2,211 | 1,756 | 1,934 | 1,839 |
| EBITDA 1 | 168.4 | 213.8 | 267.5 | 128.1 | 0.652 | -41.96 |
| EBIT 1 | 21.12 | 75.29 | 131.4 | -13.34 | -155.2 | -197.4 |
| Net income 1 | 62.43 | 87.41 | 91.02 | 6.209 | -127.2 | -180.3 |
| Net Debt 1 | 1,607 | 1,718 | 1,992 | 2,367 | 2,784 | 2,574 |
| Reference price 2 | 61.73 | 68.92 | 70.19 | 68.01 | 58.83 | 59.50 |
| Nbr of stocks (in thousands) | 65,723 | 66,251 | 66,748 | 66,894 | 67,135 | 67,285 |
| Announcement Date | 3/24/21 | 3/30/22 | 3/15/23 | 3/15/24 | 3/31/25 | 3/31/26 |
1TWD in Million2TWD
Estimates
| P/E (N) | EV / Sales (N) | EV / EBITDA (N) | Dividend Yield (N) | Capi.($) | ||
|---|---|---|---|---|---|---|
| - | - | - | - | 140M | ||
| -56.18x | 16.84x | -123.24x | -.--% | 21.61B | ||
| 17.26x | 1.96x | 8.16x | 1.49% | 9.69B | ||
| 23.57x | 4.46x | 12.55x | - | 6.79B | ||
| -56.18x | 8.67x | -72.79x | -.--% | 5.81B | ||
| 18.87x | 6.47x | 14.62x | 3.05% | 5.1B | ||
| 177.67x | 4.47x | 29.29x | -.--% | 4.94B | ||
| 20.23x | 3.55x | 11.05x | 1.88% | 4.21B | ||
| 16.29x | - | - | 3.93% | 2.74B | ||
| Average | 20.19x | 6.63x | -17.19x | 1.48% | 6.78B | |
| Weighted average by Cap. | -1.80x | 9.17x | -45.68x | 0.9% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- 4737 Stock
- Valuation Bionime Corporation
Select your edition
All financial news and data tailored to specific country editions
















